BREA,
Calif., Jan. 11, 2024 /PRNewswire/ -- Envista
Holdings Corporation (NYSE: NVST) ("Envista") will report financial
results for its fourth quarter 2023 on Wednesday, February 7,
2024. Envista will discuss these results on a conference call on
the same day beginning at 2:00 PM PT and lasting approximately
one hour.
The call and the accompanying slide presentation will be webcast
on the "Investors" section of Envista's website, www.envistaco.com.
A replay of the webcast will be available shortly after the
conclusion of the presentation and will remain available for one
year. You can access the conference call by dialing
800-225-9448 within the U.S. or +1 203-518-9708 outside
the U.S. a few minutes before 2:00 PM PT and referencing
conference ID #7305894.
Envista's earnings press release, the webcast slides, and other
related presentation materials will be posted to the "Investors"
section of Envista's website before the conference call and will
remain available following the call.
ABOUT ENVISTA HOLDINGS
CORPORATION
Envista is a global family of more than 30 trusted dental
brands, including Nobel Biocare, Ormco, DEXIS, and Kerr, united by
a shared purpose: to partner with professionals to improve lives.
Envista helps its customers deliver the best possible patient
care through industry-leading dental consumables, solutions,
technology, and services. Its comprehensive portfolio,
including dental implants and treatment options, orthodontics, and
digital imaging technologies, covers a wide range of dentists'
clinical needs for diagnosing, treating, and preventing dental
conditions as well as improving the aesthetics of the human smile.
With a foundation comprised of the proven Envista Business
System (EBS) methodology, an experienced leadership team, and a
strong culture grounded in continuous improvement, commitment to
innovation, and deep customer focus, Envista is well equipped to
meet the end-to-end needs of dental professionals worldwide.
Envista is one of the largest global dental products
companies, with significant market positions in some of the most
attractive segments of the dental products industry. For more
information, please visit www.envistaco.com.
FOR FURTHER
INFORMATION
Stephen Keller
Principal Financial Officer
Envista Holdings Corporation
200 S. Kraemer Blvd., Building E
Brea, CA 92821
Telephone: (714) 817-7000
ir@envistaco.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/envista-schedules-fourth-quarter-2023-earnings-call-302033090.html
SOURCE Envista Holdings Corporation